S. Casabona

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

J. Gisbert, D. Bernardo, S. Fernández-Tomé, 2018, Mucosal Immunology.

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

E. Savarino, E. Laserna-Mendieta, A. Lucendo, 2020, Alimentary pharmacology & therapeutics.

EFFICACY OF THERAPY FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE.

E. Savarino, E. Laserna-Mendieta, A. Lucendo, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

E. Savarino, S. Carrión, S. Fernández-Fernández, 2022, United European gastroenterology journal.

Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.

E. Savarino, E. Laserna-Mendieta, A. Lucendo, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

T. Cavero, F. Sánchez‐Madrid, I. González-Álvaro, 2020, Journal of Allergy and Clinical Immunology.

Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease

J. Gisbert, D. Bernardo, S. Fernández-Tomé, 2022, Biomedicines.

Proteomic analysis of the esophageal epithelium reveals key features of eosinophilic esophagitis pathophysiology

E. Laserna-Mendieta, L. Arias-González, A. Lucendo, 2023, Allergy.

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c−CCR2−CX3CR1− counterparts, are expanded in inflammatory bowel disease

J. Gisbert, D. Bernardo, S. Fernández-Tomé, 2018, Mucosal Immunology.

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

L. Arias-González, M. Pérez-Fernández, C. Santander, 2023, medRxiv.

Proton pump Inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction and evaluation of treatment response

E. Laserna-Mendieta, L. Arias-González, M. Azkargorta, 2023, medRxiv.